Participant in Pfizer’s Duchenne gene therapy trial passes away.
Patient Dies in Pfizer Study of Duchenne Gene Therapy In an unfortunate turn of events, a patient participating in a clinical trial for a novel gene therapy aimed at treating Duchenne muscular dystrophy (DMD) has died, according to an announcement from Pfizer. This study was part of the biopharmaceutical giant’s ambitious efforts to pioneer treatments […]
Pioneering infrastructure for the rapid advancement of electrical energy intelligence.
Leading Infrastructure to Accelerate Electric Power Intelligence In the rapidly evolving world of energy, the acceleration of electric power intelligence stands at the forefront of innovation and sustainability. As the demand for clean, renewable energy sources soars, the infrastructure supporting this transformation plays a crucial role in shaping a sustainable future. This article explores the […]
CDC Director Mandy Cohen Discusses Public Health Preparedness at Milken Institute Conference
Enhancing Public Health Preparedness: Insights from CDC Director Mandy Cohen at the Milken Institute Conference In a significant panel discussion at the recent Milken Institute conference, Dr. Mandy Cohen, Director of the Centers for Disease Control and Prevention (CDC), shared her expert insights on public health preparedness, underlining the essential steps the nation must undertake […]
Gossamer divests rights to promising drug aimed at competing with recent Merck treatment.
Gossamer Sells Rights to Drug in Anticipation of Competing with New Merck Therapy In a strategic move that underscores the fierce competition within the pharmaceutical sector, Gossamer Bio has announced the sale of rights to one of its promising drugs, potentially setting the stage for a direct competition with a novel therapy developed by Merck. […]
Opinion: Readers React to Financial Support for Academic Medical Institutions, the ‘Residency Research Competition,’ and Beyond.
Exploring the Contours of Academic Medical Funding and the Residency Research Arms Race: A Reader-driven Dialogue The complexities of funding academic medical centers, coupled with the competitive fervor dubbed as the residency research arms race, have stirred a vibrant dialogue among our readership. These topics touch the core of medical education, research, and ultimately, patient […]
Court of Appeals reverses $1.6 billion judgment on mainframe software ‘theft’ case against IBM.
Appeal court overturns $1.6bn mainframe software ‘poaching’ ruling against IBM In a landmark decision that has reverberated through the technology sector, an appeal court has overturned a $1.6 billion ruling against International Business Machines Corp. (IBM). The initial ruling had accused IBM of engaging in illegal poaching of mainframe software, an allegation that has now […]
STAT+: Four Critical Inquiries Regarding Amgen’s Obesity Medication as a Rival to Wegovy and Zepbound.
Exploring Amgen’s Entry into the Obesity Drug Market: A Potential Challenge to Wegovy and Zepbound The pharmaceutical industry is buzzing with anticipation as Amgen, a leading biotechnology firm, unveils its latest venture into the obesity treatment sector. With obesity rates soaring globally, the demand for effective therapeutic solutions has never been higher. Amgen’s new drug […]
Amgen stock surges as leaders detail plans to promote obesity medication.
Amgen Shares Soar as Executives Outline Obesity Drug Push In a significant turn of events, Amgen Inc., a forerunner in the biotechnology industry, has witnessed a dramatic surge in its stock price. This uptick comes after senior executives unveiled ambitious plans to broaden the company’s portfolio through the development of an innovative obesity drug. This […]
The Digital Outbreak: The Impact of AI-Generated Deepfakes on Future Security and Identification Checks.
The Cyber Pandemic: AI Deepfakes and the Future of Security and Identity Verification The digital age is dawning upon an era of hyper-connectivity, where the leaps in technological advancements are both awe-inspiring and alarming. Among these advancements, artificial intelligence (AI) has been a double-edged sword, offering solutions to complex problems while introducing new challenges. In […]
STAT+: Legislators Not Expected to Permanently Extend Flexibilities for Telehealth This Year.
Legislative Roadblocks Hinder Permanent Extension of Telehealth Flexibilities Despite broad bipartisan support and strong backing from the healthcare sector, efforts to permanently extend telehealth flexibilities—granted temporarily during the COVID-19 pandemic—are now facing significant legislative challenges. These challenges are likely to stall any permanent changes to telehealth regulations this year, according to sources familiar with the […]